Taiyen Financial Statements From 2010 to 2024

1737 Stock  TWD 32.10  0.10  0.31%   
Taiyen Biotech financial statements provide useful quarterly and yearly information to potential Taiyen Biotech Co investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Taiyen Biotech financial statements helps investors assess Taiyen Biotech's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Taiyen Biotech's valuation are summarized below:
Taiyen Biotech Co does not presently have any fundamental trend indicators for analysis.
Check Taiyen Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Taiyen Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . Taiyen financial statements analysis is a perfect complement when working with Taiyen Biotech Valuation or Volatility modules.
  
This module can also supplement various Taiyen Biotech Technical models . Check out the analysis of Taiyen Biotech Correlation against competitors.

Taiyen Biotech Co Company Current Valuation Analysis

Taiyen Biotech's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current Taiyen Biotech Current Valuation

    
  4.82 B  
Most of Taiyen Biotech's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Taiyen Biotech Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, Taiyen Biotech Co has a Current Valuation of 4.82 B. This is 75.16% lower than that of the Food Products sector and 86.45% lower than that of the Consumer Staples industry. The current valuation for all Taiwan stocks is 71.01% higher than that of the company.

Taiyen Biotech Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Taiyen Biotech's current stock value. Our valuation model uses many indicators to compare Taiyen Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Taiyen Biotech competition to find correlations between indicators driving Taiyen Biotech's intrinsic value. More Info.
Taiyen Biotech Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.54  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Taiyen Biotech Co is roughly  1.86 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Taiyen Biotech's earnings, one of the primary drivers of an investment's value.

About Taiyen Biotech Financial Statements

Taiyen Biotech investors use historical fundamental indicators, such as Taiyen Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Taiyen Biotech. Please read more on our technical analysis and fundamental analysis pages.
Taiyen Biotech Co., Ltd. provides various health and beauty products under the TAIYEN brand Hong Kong, Taiwan, Mainland China, and Macau. The company was founded in 1952 and is based in Tainan, Taiwan. TAIYEN BIOTECH is traded on Taiwan Stock Exchange in Taiwan.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Taiyen Stock Analysis

When running Taiyen Biotech's price analysis, check to measure Taiyen Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Taiyen Biotech is operating at the current time. Most of Taiyen Biotech's value examination focuses on studying past and present price action to predict the probability of Taiyen Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Taiyen Biotech's price. Additionally, you may evaluate how the addition of Taiyen Biotech to your portfolios can decrease your overall portfolio volatility.